Clinical trial

A Study of DM001 in Patients With Advanced Solid Tumors

NCT06475937

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-10-24

PhasePHASE1

Study timeline

Study start (actual)2024-10-24Date precision: day

Registry last updated2026-08-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Carcinoma, Non-Small-Cell Lungunresolved

Solid Carcinomaunresolved

Interventions

DM001DRUG

Sponsors & collaborators

Xadcera Biopharmaceutical (Suzhou) Co., Ltd.lead sponsor

Mapped research locations

HoustonTexas, United States1 NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06475937 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.